Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Beijing Biotech
Orano Med LLC
Cellectar Biosciences, Inc.
Filamon LTD
Neonc Technologies, Inc.
Essen Biotech
Essen Biotech
Sapience Therapeutics
xCures
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Mayo Clinic
Degron Therapeutics Co.
Massive Bio, Inc.
Incyte Corporation
University of Arizona
AVM Biotechnology Inc
Dana-Farber Cancer Institute
Chinese PLA General Hospital
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.